Elbasvir-Grazoprevir Zepatier
Glecaprevir-Pibrentasvir Mavyret
Ledipasvir-Sofosbuvir Harvoni
Ribavirin Copegus, Rebetol, Ribasphere
Sofosbuvir Sovaldi
Sofosbuvir-Velpatasvir Epclusa
Sofosbuvir-Velpatasvir-Voxilaprevir VoseviNot Found!
Unfortunately the page you requested was not found.
Perhaps you can find what you were looking for on this page.
Section Navigation
Section Navigation
Evaluation and Preparation for Hepatitis C Treatment Overview4th Edition
Module Core Competency
Provide Evidence-Based Evaluation and Preparation for Treatment of Persons with Hepatitis C Infection
Target Audience
For clinicians evaluating persons with chronic HCV infection for hepatitis C treatment, including clinicians who will independently assess treatment candidacy and clinicians who will provide treatment candidacy with assistance from a hepatitis C expert.
Editors
John D. Scott, MD
, John D. Scott, MD
Assistant Director Hepatitis and Liver Clinic
Harborview Medical Center
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Assistant Director Hepatitis and Liver Clinic
Harborview Medical Center
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Disclosures: Consulting: Gilead Sciences
David H. Spach, MD
David H. Spach, MD
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Professor of Medicine
Division of Allergy & Infectious Diseases
University of Washington
Disclosures: None
Free CNE/CME
Module Lessons
1Lesson 1 Goals and Benefits with HCV Treatment
- Learning Objectives
- Cite the goals and rationale for HCV therapy in persons with chronic HCV
- Discuss durability of sustained virologic response when achieved with direct-acting antiviral therapy
- List several long-term benefits of HCV treatment on clinical outcomes in persons with chronic HCV
- Describe the impact of HCV treatment on survival
- Summarize the population-level benefit of HCV treatment
- Quick ReferenceGoals and Benefits with HCV Treatment Core Concepts
2Lesson 2 Making a Decision on When to Initiate HCV Therapy
- Learning Objectives
- Summarize current recommendations for HCV treatment indications in persons with chronic HCV
- List absolute contraindications for HCV treatment with direct-acting antiviral therapy
- Discuss relative contraindications for HCV treatment with direct-acting antiviral therapy
- Describe key patient readiness factors to assess prior to initiating treatment
- Outline general monitoring recommendations when HCV treatment is deferred
- Quick ReferenceMaking a Decision on When to Initiate HCV Therapy Core Concepts
3Lesson 3 Addressing Barriers to HCV Treatment
- Learning Objectives
- State the key steps in HCV care continuum
- List major barriers to hepatitis C testing
- Describe approaches for improving linkage to hepatitis C care services
- Explain potential insurance and Medicaid restrictions that can limit access to HCV treatment
- Discuss strategies for expanding hepatitis C medical provider capacity
- Quick ReferenceAddressing Barriers to HCV Treatment Core Concepts
- Background
- The Path to HCV Cure: HCV Care Continuum
- HCV Testing: Access, Efficiency, and Reimbursement
- Improving Services for Linkage-to-Care
- Expanding Medical Provider Capacity
- Expanding Settings for HCV Clinical Care and Treatment
- Insurance and Medicaid Restrictions to HCV Treatment Access
- Summary Points
Check
-On-
Learning
Questions
-On-
Learning
Questions
The Check-on-Learning Questions are short and topic related. They are meant to help you stay on track throughout each lesson and check your understanding of key concepts.